跳至主導覽 跳至搜尋 跳過主要內容

A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren

  • Wen Pyng Wu
  • , Chi Hao Chang
  • , Yung Tsung Chiu
  • , Cheng Lung Ku
  • , Mei Chin Wen
  • , Kuo Hsiung Shu
  • , Ming Ju Wu*
  • *此作品的通信作者
  • China Medical University Taichung
  • Show-Chwan Memorial Hospital Taiwan
  • National Yang Ming Chiao Tung University
  • Veterans General Hospital-Taichung Taiwan
  • Chung Shan Medical University
  • National Chung Hsing University

研究成果: 期刊稿件 › 文章 › 同儕審查

58 引文 斯高帕斯(Scopus)

摘要

The protective effect of combination therapy with valsartan and aliskiren against renal fibrosis remains to be defined. This study was undertaken to examine the protective effects of the combination of valsartan and aliskiren against renal fibrosis induced by unilateral ureteral obstruction (UUO). Combination therapy with valsartan (15 mg·kg-1·day -1) and aliskiren (10 mg·kg-1·day -1), valsartan monotherapy (30 mg·kg -1·day-1), and aliskiren monotherapy (20 mg·kg-1·day-1) all significantly ameliorated the increase in blood urea nitrogen and the degree of hydronephrosis determined by the increase in weight and length of the obstructed kidney. The dose titration study and blood pressure measurement confirmed that the combination therapy provided a greater benefit independent of the vasodilatory effect. There were no significant changes in serum levels of creatinine, sodium, and potassium in UUO rats and any treatment groups. Combination therapy also attenuated UUO-related increases in the scores of tubular dilatation, interstitial volume, interstitial collagen deposition, α-smooth muscle actin, the activation of ERK 1/2, the infiltration of monocytes/macrophages, the mRNA expression of snail-1, and transforming growth factor-β1 to a greater extent compared with aliskiren or valsartan used alone. The mRNA expression of renin and the (pro)renin receptor significantly increased after UUO. Combination therapy and monotherapy of valsartan and aliskiren had a comparable enhancing effect on the mRNA expression of renin, whereas all these treatments did not affect the expression of the (pro)renin receptor. In conclusion, a direct renin inhibitor in conjunction with an angiotensin II receptor blocker exerts increased renal protection against renal fibrosis and inflammation during obstruction over either agent alone.

原文英語
頁(從 - 到)F929-F941
期刊American Journal of Physiology - Renal Physiology
卷299
發行號5
DOIs
出版品狀態已出版 - 11 2010
對外發佈是

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren」主題。共同形成了獨特的指紋。

引用此